HT Vet will be exhibiting at BVA Live 2026 on stand E55, where visitors can experience live demonstrations of its latest innovation, VISTA iQ.

VISTA iQ is a non-invasive, AI-powered screening device designed to support the early detection of cancer in dogs presenting with lumps and bumps. Using advanced Heat Diffusion Imaging (HDI) technology, the device safely applies and measures thermal changes within tissue, which are then analysed using artificial intelligence to assess cancer risk and guide next steps in the diagnostic pathway.

The system delivers results within minutes, directly in the consultation room, enabling veterinary teams to make faster, more informed clinical decisions without the need for immediate invasive testing. Its wireless, portable design and intuitive interface allow it to be easily integrated into everyday workflows, while also enabling veterinary nurses to take an active role in running screening appointments.

For veterinary clinics, VISTA iQ offers both clinical and operational benefits. It helps reduce reliance on a “wait and see” approach, supports earlier detection of potentially malignant masses, and improves client communication by providing immediate, objective insights. At the same time, it can enhance workflow efficiency, optimise team utilisation, and create new revenue opportunities through increased diagnostic uptake.

Delegates visiting the stand will have the opportunity to see the device in action, understand how it fits into routine consultations, and explore how it can support both patient outcomes and practice performance.

The HT Vet team will be on hand throughout the event to answer questions, discuss real-world use cases, and offer guidance on implementing VISTA iQ in practice.

Visit stand E55 to discover how VISTA iQ is helping to advance early cancer detection and support smarter, more efficient veterinary care.

Learn more about HT Vet and the VISTA iQ here: https://ht-vet.com/